Precocious puberty: McCune-Albright syndrome and beyond

Journal of Pediatrics

Volumn 143, Issue 1, 2003, Pages 9-10

  Saenger, Paul ^a   Rincon, Marielisa ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; LEUPRORELIN; NORALDEX; TAMOXIFEN;

ADOLESCENT; ALBRIGHT SYNDROME; BODY HEIGHT; BONE AGE; CENTRAL NERVOUS SYSTEM TUMOR; EDITORIAL; ENDOCRINOLOGY; FEMALE; GENE MUTATION; HORMONAL THERAPY; HUMAN; MALE; MENARCHE; OBESITY; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SYMPTOMATOLOGY;

EID: 0042243570     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(03)00272-5     Document Type: Editorial

References (16)

1. Rosenfield RL. Normal and almost normal variants of precocious puberty: premature pubarche and premature thelarche revisited. Horm Res 1994;41:7.
2. Lee PA. Central precocious puberty. An overview of diagnosis, treatment, and outcome. Endocrinol Metab Clin North Am 1999;28:901-18.
3. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Setting network. Pediatrics 1997;99:505-12.
4. Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implication for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins pediatric Endocrine Society. Pediatrics 1999;104:936-41.
5. Rosenfield RL, Bachrach LK, Chemausek SD, Gertner JM, Gottschalk M, Hardin DS, et al. Current age of onset of puberty. Pediatrics 2000;106:622-3.
6. New York Times. Doubters fault theory finding earlier puberty. February 20, 2001; A1, A16.
7. Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign? Pediatrics 2003;111:47-51.
8. Eugster E, Rubin S, Reiter E, Plourde P, Jou H, Pescovitz O. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 2003;143:61-7.
9. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the α subunit of the stimulatory G protein of adenyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 1992;89:5152.
10. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Eng J Med 1991;325:1688.
11. Styne DM. The testes. In: Sperling MA, editor. Disorders of sexual differentiation and puberty in the male. Pediatric endocrinology. Philadelphia: Saunders; 2002. p. 611.
12. Lala R, Matarazzo P, Bertelloni S, Buzzi F, Rigon F, de Sanctis C. Pamidronate treatment of fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 2000;89:88-92.
13. Kappy MS, Stuart TE, Perelman AH, Clemons RD. Supression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depo) in children with precocious puberty. J Clin Endocrinol Metab 1989;87:1087-9.
14. Carel J, Lahlou N, Jaramillo O, Montauban V, Tenturier C, Colle M, et al. Treatment of central precocious puberty by subcutaneous injection of Leuprorelin 3-month Depo (11.25 mg). J Clin Endocrinol Metab 2002;87:4111-6.
15. Bhatia S, Neely K, Wilson D. Serum luteinizing hormone rises within minutes after Depo Leuprolide injection: implications for monitoring therapy. Pediatrics 2002;109:1-6.
16. Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 1995;126:955-8.